# Sanguinaria canadensis (Bloodroot)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/sanguinaria-canadensis
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-23
**Evidence Score:** 2 / 10
**Category:** Herb
**Also Known As:** Sanguinaria canadensis, Canadian Puccoon, Red Puccoon, Redroot, Tetterwort, White Puccoon, Indian Paint, Snakebite

## Overview

Sanguinaria canadensis, commonly called bloodroot, contains the primary bioactive alkaloid sanguinarine, which disrupts bacterial cell membranes and inhibits NF-κB-mediated inflammatory signaling. It has been studied for [antimicrobial](/ingredients/condition/immune-support), [anti-inflammatory](/ingredients/condition/inflammation), and potential antineoplastic applications, though most evidence remains at the in vitro or early preclinical stage.

## Health Benefits

["\u2022 Exhibits antiseptic and [anti-inflammatory](/ingredients/condition/inflammation) effects, according to preliminary in vitro evidence.[1]", "\u2022 Demonstrates [antimicrobial](/ingredients/condition/immune-support) activity in laboratory studies, causing bacterial aggregation and morphological irregularities.[1][3]", "\u2022 May influence immune responses, though a mouse macrophage model found that high endotoxin levels in extracts, rather than the alkaloids, were the primary drivers of IL-10 production.[2]", "\u2022 Contains a high concentration of benzophenanthridine alkaloids, with sanguinarine comprising approximately 44-50% of the total alkaloid content.[1][3][5]", "\u2022 Shows cytotoxic potential in cell line studies, indicating a need for further safety evaluation before any therapeutic consideration.[3]"]

## Mechanism of Action

Sanguinarine, the primary benzophenanthridine alkaloid in Sanguinaria canadensis, intercalates into bacterial DNA and disrupts cell membrane integrity, causing morphological irregularities and aggregation in gram-positive and gram-negative organisms. It inhibits the NF-κB signaling pathway by blocking IκB kinase activation, thereby reducing downstream transcription of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as TNF-α and IL-6. Additionally, sanguinarine inhibits [acetylcholine](/ingredients/condition/cognitive)sterase and interacts with topoisomerase II, which underlies preliminary interest in its cytotoxic and antineoplastic activity.

## Clinical Summary

The majority of evidence for Sanguinaria canadensis derives from in vitro cell studies and animal models rather than robust human clinical trials. A notable application involved sanguinarine-containing toothpastes and mouthrinses, where small controlled trials (typically under 100 participants) demonstrated modest reductions in dental plaque and gingivitis scores compared to placebo, though later research raised concerns about leukoplakia risk with prolonged oral use. Mouse model studies suggest [immunomodulatory](/ingredients/condition/immune-support) effects, but translating these findings to human dosing and efficacy remains unestablished. Overall, the evidence base is preliminary and insufficient to support broad therapeutic claims.

## Nutritional Profile

Sanguinaria canadensis (Bloodroot) is a medicinal herb, not a dietary food source, so conventional macronutrient and micronutrient profiling is not applicable in standard nutritional terms. Its profile is defined primarily by its bioactive alkaloid content. Key bioactive compounds include: Sanguinarine (primary alkaloid, benzophenanthridine class, comprising approximately 0.5–6% of dried rhizome by weight depending on extraction method and plant part), Chelerythrine (second major alkaloid, typically present at 0.1–1% of dry rhizome weight), Berberine (minor alkaloid, trace to ~0.1% dry weight), Coptisine (trace levels), Protopine (trace levels), Homochelidonine (trace levels), and Allocryptopine (trace levels). The rhizome and root contain the highest alkaloid concentrations compared to aerial parts. Sanguinarine exists in equilibrium between its iminium (charged) and alkanolamine (neutral) forms, affecting bioavailability — the iminium form predominates at physiological pH and is the more biologically active species. No meaningful dietary fiber, protein, fat, carbohydrate, vitamin, or mineral content is documented at therapeutically or nutritionally relevant levels in standard use quantities. Tannins and resins are present in the rhizome at low levels. Oral bioavailability of sanguinarine is considered low due to poor gastrointestinal absorption and rapid first-pass [metabolism](/ingredients/condition/weight-management); topical and mucosal absorption pathways are better characterized. Extract endotoxin contamination has been noted in research preparations, which may confound biological activity studies.

## Dosage & Preparation

No clinically studied or standardized dosage ranges for Sanguinaria canadensis exist due to a complete absence of human clinical trials. Historical 19th-century preparations, which lack modern clinical validation, mention powders containing 2 grains of sanguinaria combined with other substances.[4] Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Sanguinarine is considered toxic at elevated doses; internal ingestion of bloodroot extract can cause severe mucosal irritation, nausea, vomiting, and in high doses, hypotension and central nervous system depression. Prolonged topical oral exposure to sanguinarine-containing products has been epidemiologically linked to oral leukoplakia, a potentially precancerous condition, leading to significant safety concerns. Bloodroot may interact with anticoagulants and cytochrome P450-metabolized drugs due to alkaloid-mediated enzyme modulation. It is contraindicated during pregnancy and lactation and should not be used internally without medical supervision.

## Scientific Research

The provided research lacks any human clinical trials, randomized controlled trials (RCTs), or meta-analyses for Sanguinaria canadensis. Available data is limited to in vitro, animal, or phytochemical studies, and no PubMed PMIDs for human trials were identified.[2][3]

## Historical & Cultural Context

Bloodroot has a history of use in traditional North American medicine, where its roots, which yield a characteristic red latex, were utilized. In the 19th century, it was prepared as powders or tinctures and was sometimes combined with substances like opium for unspecified ailments.[4][5]

## Synergistic Combinations

Information not available in provided research.

## Frequently Asked Questions

### What is sanguinarine and why is it important in bloodroot?

Sanguinarine is a benzophenanthridine alkaloid and the principal bioactive compound in Sanguinaria canadensis, comprising a significant portion of the root's alkaloid content. It is responsible for the plant's antimicrobial, anti-inflammatory, and cytotoxic activities, acting by intercalating bacterial DNA and suppressing NF-κB inflammatory signaling. Its potency also accounts for much of the plant's toxicity profile at higher doses.

### Is bloodroot safe to take orally as a supplement?

Internal use of bloodroot is associated with significant safety risks, including mucosal irritation, nausea, vomiting, and systemic toxicity at doses beyond trace amounts. Prolonged oral exposure to sanguinarine has been linked to oral leukoplakia in epidemiological studies of users of sanguinarine-based dental products. Most herbalists and clinicians do not recommend internal supplementation without direct medical oversight due to its narrow therapeutic margin.

### Has bloodroot been clinically proven to treat any condition?

No condition has been approved or conclusively validated through large-scale human clinical trials using Sanguinaria canadensis. Small controlled trials on sanguinarine-containing dental rinses showed modest plaque and gingivitis reduction, but these products were subsequently scrutinized for leukoplakia risk. All other applications, including anticancer and immune-modulating uses, remain at the in vitro or animal model stage as of current evidence.

### Can bloodroot interact with prescription medications?

Sanguinarine may inhibit cytochrome P450 enzymes, particularly CYP3A4, potentially altering the metabolism and plasma levels of drugs processed by this pathway, including certain statins, benzodiazepines, and immunosuppressants. There is also theoretical risk of additive effects when combined with anticoagulants due to possible platelet function modulation. Patients on prescription medications should consult a healthcare provider before using any bloodroot-containing product.

### What did traditional Native American medicine use bloodroot for?

Indigenous North American peoples, including the Algonquin and Iroquois, used Sanguinaria canadensis root paste topically as a caustic agent to treat skin tags, warts, and fungal skin conditions, exploiting its escharotic (tissue-destroying) properties. It was also used in small quantities as an emetic and expectorant for respiratory complaints. These traditional uses align with the plant's known antimicrobial and cytotoxic alkaloid chemistry, though historical application does not substitute for modern clinical evidence of safety or efficacy.

### What are the different forms of bloodroot available as supplements, and how do they differ?

Bloodroot is available as dried powder, liquid extracts, and topical preparations, with formulations varying significantly in alkaloid concentration and endotoxin content. Liquid extracts may offer more consistent dosing of active compounds compared to whole plant powder, though the presence of endotoxins in crude preparations can affect immune response independently of the alkaloids themselves. Topical applications differ fundamentally from oral supplements in their intended use and absorption pathway, making form selection dependent on the specific health goal.

### Who should avoid taking bloodroot supplements, and are there specific populations at higher risk?

Pregnant and nursing women should avoid bloodroot due to insufficient safety data and the potential for alkaloids to cross biological barriers. Individuals with gastrointestinal conditions, autoimmune disorders, or high sensitivity to endotoxins may experience adverse reactions, as preliminary research suggests endotoxin levels in extracts can trigger immune responses. People taking immunosuppressants or with compromised immune function should consult a healthcare provider before use.

### How strong is the scientific evidence for bloodroot's antimicrobial and anti-inflammatory claims?

Current evidence for bloodroot's antimicrobial activity is limited to laboratory (in vitro) and animal studies, which demonstrate bacterial morphological changes but have not been conclusively replicated in human clinical trials. Anti-inflammatory effects are similarly preliminary and based on in vitro models rather than human clinical data, meaning efficacy in living organisms remains unproven. The confounding factor of endotoxin contamination in many extracts complicates interpretation of study results, as observed immune effects may not derive from the alkaloids alone.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*